Abstract  Description  Claims  Drawing  Search report  Cited references 

WO20100723353A   [0010] 
WO0241920A   [0012] 
WO2004009085A   [0013] 
WO2006035313A   [0014] 
EP1025858A   [0015] 
WO2007130773A   [0016] 
EP2387993A   [0017] 
WO2013058496A   [0018] 
WO2010072353A   [0019] 
WO2007070504A   [0020] 
WO0137816A   [0021] 
WO200570417A   [0021] 
GB201006489A   [0021] 
US4816470A   [0039] 
US5466699A   [0039] 
WO9206973A   [0039] 
EP0497512A   [0039] 
WO9402460A   [0039] 
WO9300086A   [0039] 
EP0303507A   [0039] 

Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine   [0008] 
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet   [0008] 
Formulation and Optimization of Orally Disintegrating Tablets of Sumatriptan Succinate   [0010] 
Recent Patents and Patented Technology Platforms for Pharmaceutical Taste Masking   [0010] 
Handbook of pharmaceutical excipients   [0055] 
Aulton's Pharmaceutics. The design and manufacture of medicines   [0079] 
Remington: The Science and Practice of Pharmacy   [0079] 
Experiments with Mixtures   [0092]